3 hours ImmunityBio (NASDAQ:IBRX) Upgraded to Strong-Buy by EF Hutton Acquisition Co. IMarketBeat
EF Hutton Acquisition Co. I raised ImmunityBio to a “strong-buy” rating in a research report on Wednesday.
XEF Hutton Acquisition Co. I raised ImmunityBio to a “strong-buy” rating in a research report on Wednesday.
X